Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P09486: Variant p.Arg166His

SPARC
Gene: SPARC
Feedback?
Variant information Variant position: help 166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Histidine (H) at position 166 (R166H, p.Arg166His). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (H) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In OI17; decreased secretion of the protein; altered secretion of procollagen type I. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 166 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 303 The length of the canonical sequence.
Location on the sequence: help IGPCKYIPPCLDSELTEFPL R MRDWLKNVLVTLYERDEDNN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IGPCKYIPPCLDSELTEFPLRMRDWLKNVLVTLYERDEDNN

Mouse                         IGPCKYIAPCLDSELTEFPLRMRDWLKNVLVTLYERDEGNN

Rat                           IGPCKYIAPCLDSELTEFPLRMRDWLKNVLVTLYERDEGNN

Pig                           IGPCKYIPPCLDSELTEFPLRMRDWLKNVLVTLYERDENNN

Bovine                        IGPCKYIPPCLDSELTEFPLRMRDWLKNVLVTLYERDEDNN

Chicken                       IGPCKFIPACLDTELTEFPLRMRDWLKNVLITLYERDEDNN

Xenopus laevis                IGPCKYIAPCLDNELSEFPLRIGDWLKNVLVSLYERDENNN

Caenorhabditis elegans        LGECKKLDECTEEHMAQFPERMADWLFQVMKELKKRRELHK
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 18 – 303 SPARC
Disulfide bond 155 – 265
Mutagenesis 166 – 166 R -> ALK. Strongly reduced collagen binding.
Mutagenesis 173 – 173 N -> AQ. Strongly reduced collagen binding.
Helix 157 – 181



Literature citations
Recessive osteogenesis imperfecta caused by missense mutations in SPARC.
Mendoza-Londono R.; Fahiminiya S.; Majewski J.; Tetreault M.; Nadaf J.; Kannu P.; Sochett E.; Howard A.; Stimec J.; Dupuis L.; Roschger P.; Klaushofer K.; Palomo T.; Ouellet J.; Al-Jallad H.; Mort J.S.; Moffatt P.; Boudko S.; Baechinger H.P.; Rauch F.;
Am. J. Hum. Genet. 96:979-985(2015)
Cited for: INVOLVEMENT IN OI17; VARIANTS OI17 HIS-166 AND LYS-263; CHARACTERIZATION OF VARIANTS OI17 HIS-166 AND LYS-263;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.